SCHEMBL4617339

SCHEMBL4617339

COc1ccc(CCNS(=O)(=O)c2cc(S(=O)(=O)c3ccccc3)ccc2C)cc1OC

nearest known ligand 0.79

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 2/20 0.79
HTT P42858 2/20 0.73
ALDH1A1 P00352 4/20 0.60
PDE4B Q07343 1/20 0.59
PDE4C Q08493 1/20 0.59
PDE4D Q08499 1/20 0.59
POLB P06746 1/20 0.59
LMNA P02545 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.54
MAPT P10636 2/20 0.53
CYP19A1 P11511 1/20 0.53
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA5A P35218 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617597 0.93 SFRP1 (0.72) SFRP1HTTALDH1A1PDE4BPDE4C
SCHEMBL4616841 0.93 SFRP1 (0.72) SFRP1HTTALDH1A1PDE4BPDE4C
SCHEMBL6102774 0.93 SFRP1 (0.68) SFRP1HTTALDH1A1PDE4BPDE4C
SCHEMBL4618123 0.92 SFRP1 (0.84) SFRP1HTTALDH1A1POLBLMNA
SCHEMBL27712928 0.91 SFRP1 (0.69) SFRP1HTTALDH1A1PDE4BPDE4C
SCHEMBL4618510 0.91 ALDH1A1 (0.76) SFRP1HTTALDH1A1PDE4BPDE4C
SCHEMBL6101030 0.91 SFRP1 (0.66) SFRP1HTTALDH1A1PDE4BPDE4C
SCHEMBL4618751 0.88 SFRP1 (1.00) SFRP1HTTALDH1A1PDE4BPDE4C
SCHEMBL6104071 0.88 HTT (0.81) SFRP1HTTALDH1A1POLBLMNA
SCHEMBL4618783 0.87 SFRP1 (0.80) SFRP1HTTALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885HTT 4703/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.